# Acute Effects of GLP-1 on Renal Hemodynamics

> **NCT04337268** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 10 (actual)

## Conditions studied

- The GLP-1-mediated Gut-kidney Axis

## Interventions

- **DRUG:** Glucagon-Like Peptide 1
- **DRUG:** saline 0.9%

## Key facts

- **NCT ID:** NCT04337268
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04337268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04337268, "Acute Effects of GLP-1 on Renal Hemodynamics". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04337268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*